Britain Set to Leap Ahead in Approving Vaccines

November 27, 2020

(New York Times) – Britain asked its drug regulator on Friday to consider AstraZeneca’s coronavirus vaccine for emergency approval, forging ahead in the face of considerable uncertainty about the vaccine’s effectiveness as the government tries to corral a pandemic that has killed more than 66,000 people in the country. The request was one of a series of steps that Britain has taken to put itself near the front of the pack of countries hurrying to assess coronavirus vaccine candidates.